parkinson's disease triple agonist glp-1 gip glucagon clinical trial

parkinson's disease triple agonist glp-1 gip glucagon clinical trial Science Behind GLP 1 and Receptor Agonists for Obesity Research | News & Announcements A Dual GLP‐1/GIP Receptor Agonist

Name: parkinson's disease triple agonist glp-1 gip glucagon clinical trial Science Behind GLP 1 and Receptor Agonists for Obesity Research | News & Announcements A Dual GLP‐1/GIP Receptor Agonist
Brand: buller-pirmasens.de
SKU: 30211329653
Price: 23.60 USD
Availability: InStock
Rating: 4.4185 (17 reviews)

SKU: 30211329653

4.4

USD23.60 USD46.60

Pay in 4 interest-free payments of $5.90 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Knop FK, Aroda VR, Astrup A, et al

145 LitvinovaL.AtochinD

Zheng Y, Ye S, Huang S, Cheng Y, Zhang Y, Leng Y, et al

PMID 3031680

Van Cauter E, Leproult R, Plat L

Recent research suggests that there is a class of neurons in contact with CSF on the ependyma called CSF-contacting neurons (CSF-cNs), and the location of CSF-cNs and ciliary morphology suggests that they sense physical and chemical signals in the CSF (Orts-DelImmagine and Wyart, 2017)